Reviewed By:
Osler Jay Justo Guzon, MD (Cardiology)
Dr. Guzon graduated from the University of Missouri-Kansas City School of Medicine with a BLA and MD. He then completed his Internal Medicine Residency at St. Louis University before a fellowship in Cardiovascular Diseases at the University of Missouri-Columbia. He has since working as an invasive cardiologist with a particular interest in preventative medicine and cardiometabolic disease. Over the past several years, Dr. Guzon has served on the speaker bureaus of AstraZeneca, Lilly, Boehringer-Ingelheim, and Aralez.
Eisaku Kamakura, MD (Pulmonology)
Dr. Kamakura graduated from the Tokyo Medical and Dental University, School of Dentistry, and the Niigata University School of Medicine. He trained at Yokosuka Kyosai Hospital and held positions in the Respiratory Medicine departments at Yokosuka Kyosai Hospital, Tokyo Medical and Dental University, Ome City General Hospital, and Musashino Red Cross Hospital. In 2021, he became the specially appointed assistant professor at the Department of General Medicine, Niigata University School of Medicine.
Content updated on Mar 31, 2024
Following the Medical Content Editorial Policy
Worried about your symptoms?
Start the Chronic Thromboembolic Pulmonary Hypertension test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Swelling
Unexplained weight gain
Swollen feet
Shortness of breath
Blacking out
Edema
Unintentional weight gain
Not seeing your symptoms? No worries!
With a free 3-min Chronic Thromboembolic Pulmonary Hypertension quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms
Our AI
Your report
Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and progressive type of pulmonary hypertension that occurs due to blood clots in the pulmonary arteries (which carry blood from the right side of the heart to the lungs), causing blockage. Risk factors include cancer, blood diseases, or inflammatory diseases.
Surgery to remove the clot can potentially cure CTEPH with excellent long-term survival rates. However, lifelong medication is needed to thin the blood and prevent clots, diuretics (to remove salt and water), and oxygen (as needed).
Mullin CJ, Klinger JR. Chronic Thromboembolic Pulmonary Hypertension. Heart Fail Clin. 2018 Jul;14(3):339-351. doi: 10.1016/j.hfc.2018.02.009. PMID: 29966632.
https://www.sciencedirect.com/science/article/abs/pii/S1551713618300230?via%3DihubPapamatheakis DG, Poch DS, Fernandes TM, Kerr KM, Kim NH, Fedullo PF. Chronic Thromboembolic Pulmonary Hypertension: JACC Focus Seminar. J Am Coll Cardiol. 2020 Nov 3;76(18):2155-2169. doi: 10.1016/j.jacc.2020.08.074. PMID: 33121723.
https://www.sciencedirect.com/science/article/pii/S0735109720365943?via%3DihubAlba GA, Atri D, Darbha S, Singh I, Tapson VF, Lewis MI, Chun HJ, Yu YR, Maron BA, Rajagopal S. Chronic Thromboembolic Pulmonary Hypertension: the Bench. Curr Cardiol Rep. 2021 Aug 19;23(10):141. doi: 10.1007/s11886-021-01572-6. PMID: 34410515.
https://link.springer.com/article/10.1007/s11886-021-01572-6Nossent EJ, Meijboom LJ, Bogaard HJ, Klok FA. Chronic thromboembolic pulmonary hypertension anno 2021. Curr Opin Cardiol. 2021 Nov 1;36(6):711-719. doi: 10.1097/HCO.0000000000000907. PMID: 34433194.
https://journals.lww.com/co-cardiology/Fulltext/2021/11000/Chronic_thromboembolic_pulmonary_hypertension_anno.6.aspxLang IM, Campean IA, Sadushi-Kolici R, Badr-Eslam R, Gerges C, Skoro-Sajer N. Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension. Clin Chest Med. 2021 Mar;42(1):81-90. doi: 10.1016/j.ccm.2020.11.014. Epub 2021 Jan 12. PMID: 33541619.
https://www.sciencedirect.com/science/article/pii/S027252312030126X?via%3DihubMale, 30s
I got more answers in one minute through your site than I did in three hours with Google.
(Sep 29, 2024)
Male, 20s
My experience was great. I was worried, but the symptom checker helped me narrow down what it might be. I feel a little relieved compared to when I first started, and it gives me a starting point for what my symptoms could mean.
(Sep 27, 2024)
Male, 50s
The questions asked and possible causes seemed spot on, putting me at ease for a next-step solution.
(Sep 26, 2024)
Female, 40s
I was actually very impressed with the results it provided because, although I didn’t mention it during the questionnaire because I thought it was unrelated, it suggested I may have something I’ve actually been diagnosed with in the past.
(Sep 25, 2024)
Reviewed By:
Osler Jay Justo Guzon, MD (Cardiology)
Dr. Guzon graduated from the University of Missouri-Kansas City School of Medicine with a BLA and MD. He then completed his Internal Medicine Residency at St. Louis University before a fellowship in Cardiovascular Diseases at the University of Missouri-Columbia. He has since working as an invasive cardiologist with a particular interest in preventative medicine and cardiometabolic disease. Over the past several years, Dr. Guzon has served on the speaker bureaus of AstraZeneca, Lilly, Boehringer-Ingelheim, and Aralez.
Eisaku Kamakura, MD (Pulmonology)
Dr. Kamakura graduated from the Tokyo Medical and Dental University, School of Dentistry, and the Niigata University School of Medicine. He trained at Yokosuka Kyosai Hospital and held positions in the Respiratory Medicine departments at Yokosuka Kyosai Hospital, Tokyo Medical and Dental University, Ome City General Hospital, and Musashino Red Cross Hospital. In 2021, he became the specially appointed assistant professor at the Department of General Medicine, Niigata University School of Medicine.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.
“World’s Best Digital
Health Companies”
Newsweek 2024
“Best With AI”
Google Play Best of 2023
“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)
Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1